title: Interleukin-2 therapy after autologous bone marrow transplantation for hematologic malignancies.
authors.affiliation: Division of Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle 98195.
authors.forename: A
authors.initials: A
authors.lastname: Fefer
authors.forename: M C
authors.initials: MC
authors.lastname: Benyunes
authors.forename: C
authors.initials: C
authors.lastname: Massumoto
authors.forename: C
authors.initials: C
authors.lastname: Higuchi
authors.forename: A
authors.initials: A
authors.lastname: York
authors.forename: C D
authors.initials: CD
authors.lastname: Buckner
authors.forename: J A
authors.initials: JA
authors.lastname: Thompson
mesh_terms: D016026:Bone Marrow Transplantation; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006402:Hematologic Diseases / Q000628:therapy*; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D015979:Killer Cells, Lymphokine-Activated; D007938:Leukemia / Q000628:therapy*; D008223:Lymphoma / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D007376:Interleukin-2; D011994:Recombinant Proteins